OLZICAR ANLO (20 + 5) MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1781709510027 -
GGREM
540923110062004 -
Código de barras
7891142207593
O que a fonte publica
- Detentor do registro
- COSMED INDUSTRIA DE COSMETICOS E MEDICAMENTOS S.A.
- Princípios ativos
- BESILATO DE ANLODIPINO;OLMESARTANA MEDOXOMILA
- Embalagem
- (20 + 5) MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- C9D3 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTAGONISTAS DO CÁLCIO
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- OLZICAR ANLO (20 + 5) MG COM REV CT BL AL AL X 30
- OLZICAR ANLO
- BESILATO DE ANLODIPINO
- OLMESARTANA MEDOXOMILA
Dados completos da fonte
{
"name": "OLZICAR ANLO (20 + 5) MG COM REV CT BL AL AL X 30",
"holder": "COSMED INDUSTRIA DE COSMETICOS E MEDICAMENTOS S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891142207593"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "540923110062004",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.082.426/0002-07",
"priceRegime": "Regulado",
"productName": "OLZICAR ANLO",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "(20 + 5) MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "55.79",
"icms-12": "63.40",
"icms-17": "67.22",
"icms-18": "68.04",
"icms-19": "68.88",
"icms-20": "69.74",
"icms-21": "70.62",
"icms-22": "71.53",
"icms-23": "72.45",
"icms-17.5": "67.62",
"icms-19.5": "69.30",
"icms-20.5": "70.18",
"icms-22.5": "71.99",
"icms-12-alc": "62.64",
"icms-17-alc": "66.41",
"icms-18-alc": "67.22",
"icms-19-alc": "68.05",
"icms-20-alc": "68.90",
"icms-21-alc": "69.77",
"icms-22-alc": "70.67",
"icms-23-alc": "71.59",
"withoutTaxes": "55.12",
"icms-17.5-alc": "66.81",
"icms-19.5-alc": "68.47",
"icms-20.5-alc": "69.33",
"icms-22.5-alc": "71.12"
},
"pisCofinsList": "Positiva",
"substanceText": "BESILATO DE ANLODIPINO;OLMESARTANA MEDOXOMILA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "76.90",
"icms-12": "87.39",
"icms-17": "92.66",
"icms-18": "93.79",
"icms-19": "94.94",
"icms-20": "96.13",
"icms-21": "97.34",
"icms-22": "98.60",
"icms-23": "99.86",
"icms-17.5": "93.21",
"icms-19.5": "95.52",
"icms-20.5": "96.74",
"icms-22.5": "99.23",
"icms-12-alc": "86.60",
"icms-17-alc": "91.81",
"icms-18-alc": "92.93",
"icms-19-alc": "94.08",
"icms-20-alc": "95.25",
"icms-21-alc": "96.45",
"icms-22-alc": "97.70",
"icms-23-alc": "98.97",
"withoutTaxes": "76.20",
"icms-17.5-alc": "92.36",
"icms-19.5-alc": "94.66",
"icms-20.5-alc": "95.84",
"icms-22.5-alc": "98.32"
},
"invalidBarcodes": [],
"activeSubstances": [
"BESILATO DE ANLODIPINO",
"OLMESARTANA MEDOXOMILA"
],
"therapeuticClass": "C9D3 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTAGONISTAS DO CÁLCIO",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1781709510027",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9D3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:540923110062004"